Browse by Aston Author

Article

Wilkinson, Alexander, Lattmann, Eric, Roces, Carla B., Pedersen, Gabriel, Christensen, Dennis and Perrie, Yvonne (2018). Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01. Journal of Controlled Release, 291 , pp. 1-10.

Lattmann, Eric, Russell, Steven T, Singh, Mankaran, Narayanan, Ramesh, Balaram, Padinjarethalakal N. and Lattmann, Pornthip (2018). N‒substituted 5‒hydroxy‒pyrrol‒2‒ones based cholecystokinin‒2 antagonists as experimental anticancer agents for the treatment of lung cancer. Drug Design, Development and Therapy, 2 (4), pp. 180-189.

Lattmann, Eric, Sattayasai, Jintana, Narayanan, Ramesh, Benyamen, Julian, Balaram, Padinjarethalakal N. and Lattmann, Pornthip (2018). CCK2–Gastrin Antagonist: Development of PNB-001 (4-Chloro- 5-Hydroxy-1-Phenylethyl-5-Phenyl-1, 5-Dihydro-Pyrrol-2-one) as Anti-Inflammatory Analgesic. SAJ Pharmacy and Pharmacology, 2 (1),

Lattmann, E., Sattayasai, J., Narayanan, R., Ngoc, N., Burrell, D., Balaram, P.N., Palizdar, T. and Lattmann, P. (2017). Cholecystokinin-2/gastrin antagonists:5-hydroxy-5-aryl-pyrrol-2-ones as anti-inflammatory analgesics for the treatment of inflammatory bowel disease. MedChemComm, 8 (3), pp. 680-685.

Lattmann, Eric, Sattayasai, Jintana, Schwalbe, Carl H., Boonprakob, Yodchai, Dunn, Simon, Fajana, Feyisayo and Lattmann, Pornthip (2016). Analgesic effects of 5-alkyloxy-4-amino-2(5H)-furanones as cholecystokinin-2 antagonists. Archiv der Pharmazie, 349 (6), pp. 456-465.

Lattmann, E., Russell, S.T., Schwalbe, C.H., Shortt, A., Balaram, P.N., Theochari, E., Alharbi, M., Narayanan, R. and Lattmann, P. (2016). Cholecystokinin-1 receptor antagonists:5-hydroxy-5-aryl-pyrrol-2-ones as anticancer agents. MedChemComm, 7 (6), pp. 1138-1145.

Ponnusamy, Suriyan, Lattmann, Eric, Lattmann, Pornthip, Thiyagarajan, Thirumagal, Padinjarethalakal, Balaram N. and Narayanan, Ramesh (2016). Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action. Oncology Reports, 35 (4), pp. 2097-2106.

Chaithongyot, Supattra, Asgar, Ali, Senawong, Gulsiri, Yowapuy, Anongnat, Lattmann, Eric, Sattayasai, Nison and Senawong, Thanaset (2015). Anticancer effects of Curcuma C20-dialdehyde against colon and cervical cancer cell lines. Asian Pacific Journal of Cancer Prevention, 16 (15), pp. 6513-6519.

Sattayasai, Jintana, Bantadkit, Jirawat, Aromdee, Chantana, Lattmann, Eric and Airarat, Wanchai (2012). Antipyretic, analgesic and anti-oxidative activities of Aquilaria crassna leaves extract in rodents. Journal of Ayurveda and Integrative Medicine, 3 (4), pp. 175-179.

Salama, Rima, Sattayasai, Jintana, Gande, Arun Kumar, Sattayasai, Nison, Davis, Mike and Lattmann, Eric (2012). Identification and evaluation of agents isolated from traditionally used herbs against Ophiophagus hannah venom. Drug Discoveries and Therapeutics, 6 (1), pp. 18-23.

Singh, Harjit, Sattayasai, Jintana, Lattmann, Pornthip, Boonprakob, Yodchai and Lattmann, Eric (2010). Antidepressant/anxiolytic and anti-nociceptive effects of novel 2-substituted 1,4-benzodiazepine-2-ones. Scientia Pharmaceutica, 78 (2), pp. 155-169.